Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EMEA expands Zometa labeling

June 17, 2003

Positive phase I results for EOquin support initiation of phase II testing

June 17, 2003

Schering AG claims new antiandrogen agents for prostate cancer and other uses

June 17, 2003

Vion terminates phase I TAPET trial

June 16, 2003

Antitumor effects described for CA4P combined with carboplatin in advanced cancer

June 16, 2003

Efficacy and safety of SU-11248 assessed in advanced solid tumors

June 16, 2003

A new clinical trial to evaluate Neovastat(R) in metastatic renal cell carcinoma

June 13, 2003

Orathecin granted European orphan medical product status for pancreatic cancer

June 13, 2003

Genasense enters new combination trial in advanced breast cancer

June 13, 2003

Rutgers scientists identify novel topoisomerase inhibitors for cancer and other uses

June 13, 2003

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...